Hikma Eyes Return To Growth After Further Cutting Generics Forecasts

Injectables And Branded Increases Offset 18% Sales Slide For Generics Unit In First Half

 
• By Dave Wallace
Light at the end of the tunnel, red
Hikma sees light at the end of the tunnel for its generics business • Source: Shutterstock

More from Strategy

More from Business